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Introduction: A chorioangioma is the most common benign tumor of the placenta. The majority of pregnancies
with chorioangiomas are asymptomatic. Pregnancies with large chorioangiomas are associated with maternal and
fetal complications, such as growth restriction, cardiomegaly, congestive heart failure, fetal anemia,
thrombocytopenia, nonimmune hydrops and intrauterine fetal death. There are several modalities of treatment
published to date with various results. Our case was the third such case report published on the successful
treatment with antenatal embolization of the feeding vessel of the chorioangioma. To the best of our knowledge,
there have been no published cases about antenatal treatment of placental chorioangiomas in Saudi Arabia, or any
other Gulf state.
Case presentation: We describe the case of a 28-year-old Arab woman diagnosed at 22 weeks of gestation with a
chorioangioma. A glue material - enbucrilate (Histoacryl) - was used for embolization of the feeding vessel.
Intrauterine fetal blood transfusions were performed twice, as a treatment for fetal anemia. The fetus developed
heart failure at 30 weeks of gestation. A Cesarean section was performed and the outcome was a live baby with
right ventricular hypertrophy. The baby was admitted to our neonatal intensive care unit and discharged at 42 days
following birth in a stable condition,with follow-up with our cardiology team.
Conclusion: In this case, we found that intrauterine embolization of the feeding vessel of a chorioangioma with
Histoacryl was a valid treatment option that carried a small risk considering the good pregnancy outcome.Introduction
Chorioangiomas are the most common placental
tumors. Generally, if the tumor size is less than 4 cm it
does not cause any symptoms during pregnancy, and
will often pass undetermined until examination of the
placenta following delivery.
Giant chorioangiomas (size> 4 cm) are rare placental
tumors associated with a number of adverse effects, in-
cluding maternal complications and often poor perinatal
outcomes. The most common complications are intra-
uterine growth restriction, fetal anemia, hydrops fetalis
and heart failure, with intrauterine fetal death sometimes
resulting as a consequence. Several modalities of ante-
natal treatment for placental chorioangioma have been
introduced with various outcomes.* Correspondence: aabinasa@yahoo.com
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Our patient was a 28-year-old Arab woman, gravida 3
para 2 with a history of nonconsanguinity, with two pre-
vious full-term normal spontaneous vaginal deliveries
and an unremarkable past medical, surgical and family
history. She was referred to our hospital at 22 weeks of
gestation with severe hydramnios and a placental tumor,
for investigations and management. Our patient pre-
sented to us complaining of shortness of breath, back-
ache and abdominal pain. An ultrasound examination
revealed normal fetal growth for gestational age. Her
amniotic fluid index was 48 cm, with the deepest pocket
of 13 cm and no signs of fetal hydrops. Ultrasound mid-
dle cerebral artery peak systolic velocity (MCA PSV)
color Doppler was 48 cm/s, which was 1.71 Multiple of
Median (MoM) for gestational age. The placenta was
implanted anteriorly with a detectable vascularized
tumor measuring 42 mm×56 mm×58 mm with a no-
ticeable feeding vessel at the root (Figures 1 and 2).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Ultrasound image of the chorioangioma before intervention.
Figure 2 Ultrasound image of the highly vascularized chorioangioma..
Figure 3 Chorioangioma post embolization. Image showing
liquid glue, used for embolization of feeding vessel.
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undergo percutaneous embolization of the tumor. Employ-
ing a multidisciplinary approach involving interventional
radiology, we performed an amnioreduction of 3 L forFigure 4 Chorioangioma post embolization. Ultrasound images showinmaternal relief of symptoms, followed by injection of
1.5 mL of enbucrilate (Histoacryl; n-butyl-2-cyanoacrylate
liquid adhesive glue) diluted with Lipiodol Ultrafluide, at
ratio of 1/5, into the feeding vessel of the tumor. After
the procedure, ultrasound Doppler revealed a complete
absence of flow through the tumor (Figure 3). Cordocent-
esis was then performed and revealed a hemoglobin level
of 10 g/L with hematocrit 28%. The fetus was transfused
50 mL of O-negative blood and the post transfusion
hemoglobin level was 14 g/L with hematocrit 42%.
Chromosomal analysis revealed a normal female karyo-
type. Ultrasound was repeated one and four days post
procedure and showed a decrease in the amniotic fluid
index, of 32.2 cm with a deepest pocket of 10 cm.
The pregnancy was followed up weekly with ultra-
sound, which showed normal fetal growth, stable amni-
otic fluid index with no signs of hydrops, and no flow
through the placental tumor (Figure 4).
At 29 weeks’ gestation, ultrasound Doppler of the
MCA PSV was 76.3 cm/s. This was 1.97 MoM forg no flow through the tumor.
Figure 5 Postpartum gross examination of the placenta..
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effusion. The fetus was transfused with 50 mL of O-
negative blood. Pre- and post-transfusion hemoglobin
levels were 10.4 g/L and 14.9 g/L, with hematocrit 29%
and 44% respectively.
At 30 weeks and 2 days of gestation, an ultrasound
detected poor fetal right ventricular contractility with
enlarged thick ventricular walls and mild pericardial ef-
fusion. Ultrasound Doppler of the MCA PSV was
61.3 cm/s, which was 1.51 MoM for gestational age, and
an amniotic fluid index of 19.9 cm. Two intramuscular
injections of betamethasone 12 mg were given 24 hours
apart and then an elective Cesarean section performed.
The outcome was a live female baby weighing 1.6 kg,
with Apgar score 5, 7 and 8. No skin lesions or dys-
morphic features were seen. The baby was transferred to
the neonatal intensive care unit (NICU).
Gross examination of the placenta revealed a
yellowish, well-circumscribed firm mass measuring
5 cm× 5 cm connected by two vessels to the placenta.
Histopathologic examination revealed a placental disc
15 cm× 17 cm× 13 cm, with a three-vessel umbilical
cord that was attached peripherally and measured
9 cm× 1.5 cm (Figure 5). The weight of the placenta was
530 g. The tumor was confirmed to be a chorioangioma.
Our patient’s baby stayed in the NICU for 42 days.
Ultrasound of her head and abdomen showed no abnor-
malities. Echocardiography confirmed right ventricular
hypertrophy with a mildly dilated right ventricle and
depressed systolic function. The baby was weaned from
the ventilator. Oxygen and nitric oxide were tapered
along with inotropic medications. The baby was eventu-
ally discharged from the NICU at 42 days old with a
follow-up appointment with our cardiology team.
Discussion
Chorioangiomas are the most common benign tumors of
the placenta, with an overall prevalence of 0.9% of preg-
nancies. Large chorioangiomas (>4 cm) are occurring less
frequently, in one out of 9,000 to 50,000 pregnancies. The
majority of pregnancies with chorioangiomas are asymp-
tomatic, but pregnancies with large chorioangiomas are
associated with maternal and fetal complications, such as
growth restriction, cardiomegaly, congestive heart failure,
fetal anemia, thrombocytopenia, nonimmune hydrops and
intrauterine fetal death [1-4].
In a view of the association between placental
chorioangioma and poor pregnancy outcome, close
surveillance is recommended. The management of
this tumor remains a challenge in fetal therapy prac-
tice. If complications develop late in pregnancy, deliv-
ery should be strongly considered. Where second or
early third trimester complications occur, which are
usually more severe, in utero treatment should beconsidered, after counseling of the patient. There are
several modalities of treatment published to date,
with various results. These include endoscopic laser
coagulation of feeding vessels [5], alcohol injection
[6], microcoil embolization [7] and therapeutic
amniodrainage [8] . Our case was the third case re-
port published on the successful treatment with ante-
natal embolization of the feeding vessel of the
chorioangioma [9,10]. It is a very simple, safe and
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performed at any gestational age where facilities for
intrauterine therapy are available.
Conclusion
In this case, we found that intrauterine embolization of
the feeding vessel of a chorioangioma with Histoacryl
was a valid treatment option that carried a small risk
considering the good pregnancy outcome.
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